Drugmakers Turn Heat on Insurers by Backing Copay Limits

  (Bloomberg) — The battle over soaring U.S. drug prices is heading for the states. With the price of some treatments topping $100,000, patient groups are pushing for state laws to make sure insurers cover most of the costs. Their campaign is backed by an Read More